Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.19.1
Condensed Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Current assets    
Cash $ 137,347 $ 597,268
Receivable from related party   6,229
Prepaid expenses 45,836 110,439
Total current assets 183,183 713,936
Cash and marketable securities held in Trust Account 147,256,712 144,964,309
Interest receivable on cash and marketable securities held in Trust Account 280,628 221,157
TOTAL ASSETS 147,720,523 145,899,402
Current liabilities    
Accounts payable 1,220,538 64,581
Payable to related party 19,922  
Notes payable 1,437,500  
Accrued liabilities 382,064 772,840
Other current liabilities 231,758 221,865
Total current liabilities 3,291,782 1,059,286
Commitments and contingencies (Note 5)
Common stock subject to possible redemption, 14,268,080 and 14,309,217 shares as of March 31, 2019 and September 30, 2018, respectively, at a redemption value of $10.00 per share 139,428,740 139,840,115
Stockholders’ equity    
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; none issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized; 4,193,926 and 4,152,789 shares issued and outstanding as of March 31, 2019 and September 30, 2018 (excluding 14,268,080 and 14,309,217 shares subject to possible redemption as of March 31, 2019 and September 30, 2018, respectively) 419 415
Additional paid-in capital 6,076,342 5,664,971
Accumulated deficit (1,076,760) (665,385)
Total stockholders’ equity 5,000,001 5,000,001
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 147,720,523 $ 145,899,402